iShares Russell 1000 Growth UCITS ETF (Acc)
| Issuer: iShares |
| Asset Class: Equity |
| TER: 18bps |
| Trading Currency: GBP |
| Pays Income: False |
| Listing Date: 10 Jul 2024 |
| Ticker: R1GB |
| ISIN: IE000NITTFF2 |
This fund offers targeted exposure to large and mid-sized U.S. companies that exhibit strong growth characteristics, aiming to replicate the performance of a prominent U.S. growth equity benchmark. These companies are typically distinguished by higher-than-average growth rates in key metrics such as earnings, sales, and overall value. The portfolio is consequently weighted towards innovative and dynamic sectors, most notably Technology and Health Care, which are often at the forefront of economic expansion, disruption, and long-term structural trends. It provides a direct way to invest in the growth engine of the world's largest economy.
In a diversified portfolio, this instrument can serve as a core strategic holding for investors with a long-term investment horizon and a higher tolerance for risk, primarily seeking capital appreciation over income. It allows for participation in the potential upside of the most dynamic segments of the U.S. equity market. The distinct focus on growth means the fund's performance can be sensitive to macroeconomic factors like interest rate changes and shifts in economic sentiment. However, it concurrently offers exposure to firms with significant potential for sustained, long-term expansion, backed by the relative stability of the U.S. market.
By holding a broad basket of securities, the fund effectively mitigates the concentration risk associated with investing in individual stocks, all while maintaining a clear and defined growth-oriented profile. As a transparent and liquid investment vehicle, it presents an efficient and cost-effective method for gaining this specific market exposure, making it a valuable tool for strategic asset allocation. It is particularly suitable for investors looking to complement a value-focused strategy or to deliberately overweight the growth factor within their U.S. equity allocation.
